Two-month results are predictors of outcome in a smoking cesation program;Valor predictivo de la abstinencia tabáquica a los 2 meses de tratamiento

Medicina Clinica

Volumn 116, Issue 7, 2001, Pages 246-250

  Barrueco, Miguel ^a   Torrecilla, Miguel ^b   Maderuelo, José Ángel ^c   Ruiz, Carlos Jiménez ^d   Mezquita, Miguel Ángel Hernández ^b   Plaza, María Dolores ^b  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b Centro de Salud de San Juan   (Spain)

^c U Docente Med Comunitaria Salamanca   (Spain)

^d HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Outcome predictors; Pneumology; Primary care; Tobacco

Indexed keywords

NICOTINE; NICOTINIC AGENT;

ADULT; ARTICLE; COUNSELING; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; METHODOLOGY; SMOKING CESSATION; TIME; TREATMENT OUTCOME;

ADULT; COUNSELING; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; NICOTINE; NICOTINIC AGONISTS; SMOKING CESSATION; TIME FACTORS; TREATMENT OUTCOME;

EID: 0035941853     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(01)71786-1     Document Type: Article

References (33)

1. Encuesta Nacional de Salud 1997. Madrid: Ministerio de Sanidad y Consumo, 1999.
2. Gonźalez Enríquez J, Villar Alvarez F, Banegas Banegas JR, Rodríguez Artalejo F, Martín Moreno JM. Tendencia de la mortalidad atribuible al tabaquismo en España. Med Clin (Barc) 1997; 109: 577-582.
3. Prochaska JO, DiClemente CC. Stages and proccesses of self change of smoking: toward an integrative model of change. J Consult Clin Psychol 1983; 51: 390-395.
4. Plans P, Navas E, Tarĩn A, Rodrĩguez G. Gali N, Gayta R et al. Coste-efectividad de los métodos de cesación tabéquica. Med Clin (Barc) 1995; 104: 49-53
5. Benowitz NL. Treating tobacco addiction. Nicotine or no nicotine? N Engl J Med 1997; 337: 1230-1231.
6. McIlvain HE, Mickinney ME, Thompson AV, Tood GL. Application of the MRFIT smoking cessation program to a healthy, mixed-sex sample. Am J Prev Med 1992; 8: 165-170
7. Freund JM, D'Agostino RB, Belanger AJ, Kannel WB, Stokes J. Predictors of smoking cessation: the Framingham Study. Am J Epidemiol 1992; 135: 957-954.
8. Norregaard J, Tonnesen P, Pertersen L. Predictors and reasons for relapse in smoking cessation with nicotine and placebo. Prev Med 1993; 22: 261-271.
9. Ockene JK, Hymowitz N, Lagus J, Shaten BJ. Comparison of smokingn behaviour change for SI (special intervention) and UC (usual care) study groups. Med Prev 1991; 20: 564-573.
10. Stapleton JA, Russell MA, Feyerabend C, Wiseman SM, Gustavsson G, Sawe U et al. Dose effects and predictors of outcome in a randomized trial of transdermanl nicotine patches in general practice. Addiction 1995; 90: 31-42.
11. Tonnesen P, Paelotti P, Gustavsson G, Rusell MA, Saracci R, Gulsvik A et al. Higher dosage nicotine patens increase one-year smoking cesation rates: results from the European CEASE trial. Eur Respir J 1999; 13: 238-245.
12. Torrecilla M. Valoración y prevención del tabaquismo en consulta especializada (Neumología) y de Atención Primaria. Tesis doctoral. Universidad de Salamanca, 1999.
13. Jiménez CA, Solano S, González de Vega JM, Ruiz MJ, Flórez S. Ramos A et al. Tratamiento del tabaquismo. En: Recomendaciones SEPAR. Barcelona: Doyma, 1998; 421-436.
14. Barrueco M, Cordovilla R, Hernéndez Mezquita MA, Gonzalez JM, De Castro J, Rivas P et al. Veracidad en las respuestas de niños, adolescentes y jóvenes a las encuestas sobre el consumo de tabaco realizadas en los centras escolares. Med Clin (Barc) 1999; 112: 251-254.
15. Rusell MA, Wilson C, Taylor C, Baker CD Effect of general practitioner's advice against smoking. Br Med J 1979; 2: 231-235.
16. Stewart PJ, Rosser WW. The impact of routine advice on smoking cessation from family physicians. Can Med Assoc J 1982; 126: 1051-1054.
17. Jamrozik F. Fowler G, Vessey M. Controlled trial of three different antismoking inteventions in general practice. Br Med J 1984; 288; 1499-1503
18. Comas A. Suárez R, López ML, Cueto A. Eficacia del consejo sanitario antitabaco. Medifam 1994; 4: 67-74.
19. Slama K, Karsenty S, Hirsh A. Effectiveness of minimal intervention by general practitioners with their smoking patients: a randomised, controlled trial in France. Tobacco Control 1995; 4: 162-169.
20. Tonnesen P, Mikkelsen K, Markholst C, Ibsen A, Bendixen M, Pedersen L et al. Nurse conducted smoking cessation with minimal intervention in a lung clinical randomized controlled study. Eur Respir J 1996; 9: 2351-2355.
21. Jiménez CA, Barrueco M, Carrión F. Cordovilla R, Hernández I, Martinez E et al. Intervención mínima personalizada en el tratamiento del tabaquismo. Resultadosde un estudio multicéntrico. Arch Bronconeumol 1998; 34: 433-436.
22. Martin C, Jane C, Nebot M. Evaluación anual de un programa de ayuda al fumador. Aten Primaria 1993; 12: 86-90.
23. Strecher VJ, Kreuter M, Den Boer DJ, Kobrin S, Hospers HJ, Skinner CS. The effects of computer-tailoring smoking cessation messages in family practice settings. J Fam Pract 1994; 39: 262-270.
24. Aleixandre E, Casanova MA, Mitjas J, Sánchez J, Sanmartin A. Ensayo clinico de dos intervenciones de deshabituación tabéquica en atención primaria. Aten Primaria 1998; 22: 424-428.
25. Abelin T, Ehrsam R, Imhof P. Clinical experience with a transdermal nicotine system in healthy nicotine dependent smokers. En: Willheimsen L editor. Smoking as a cardiovascular risk factor. New strategies for smoking cessation. Lewiston NY: Hogrefe and Huber publishers, 1991; 35-46.
26. Daughton D, Heatley S, Prendergst J. Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy. A randomized, placebo-controlled, double-blind study. Arch Intern Med 1991; 151: 749-752.
27. Tonnesen P, Norregaard J, Simonsen K, Sawe U. A double blind trial of a 16-hour transdermal nicotine patch in smoking cessation. N Engl J Med 1991; 325: 311-315.
28. Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation: six month results from two multicenter controlled clinical trials. JAMA 1991; 266: 3133-3138.
29. Imperial Cancer Research Fund General Practice Research Group. Effectiveness of nicotine patch in helping people stop smoking: result of a randomised trial in general practice. Br Med J 1993; 306: 1304.
30. Russell MA, Stapleton JA, Feyerabend C, Wiseman SM, Gustavsson G, Sawe U et al. Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches. Br Med J 1993; 306: 1308-1312.
31. Moreno Ortigosa A, Ochoa Gómez FJ, Ramalle-Gomara E, Saralegui Reta I, Fernández Esteban MV, Quintana Diaz M. Eficacia de una intervención para dejar de fumar en pacientes con infarto de miocardio. Med Clin (Barc) 2000; 114: 209-210.
32. Ramón JM, Bou R, Alkiza ME, Romea S, Oromf J, Saltó E et al. Proceso de cambio y sexo como predictores del abandono del consumo de tabaco. Arch Bronconeumol 1999; 35: 488-493.
33. Barrueco M. Tratamiento del tabaquismo: situación actual y perspectiva de futuro. Med Clin (Barc) 2000; 115: 341-342.